DrugPatentWatch Database Preview
J And J Consumer Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for J AND J CONSUMER INC, and what generic alternatives to J AND J CONSUMER INC drugs are available?
J AND J CONSUMER INC has twenty-eight approved drugs.
There are four US patents protecting J AND J CONSUMER INC drugs.
There are forty-three patent family members on J AND J CONSUMER INC drugs in thirty-five countries and thirty supplementary protection certificates in thirteen countries.
Summary for J And J Consumer Inc
International Patents: | 43 |
US Patents: | 4 |
Tradenames: | 22 |
Ingredients: | 10 |
NDAs: | 28 |
Drugs and US Patents for J And J Consumer Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020325-002 | Sep 23, 2003 | OTC | Yes | Yes | Start Trial | Start Trial | |||||
J And J Consumer Inc | CHILDREN'S ZYRTEC ALLERGY | cetirizine hydrochloride | TABLET, CHEWABLE;ORAL | 021621-004 | Nov 16, 2007 | DISCN | Yes | No | Start Trial | Start Trial | |||||
J And J Consumer Inc | CHILDREN'S MOTRIN | ibuprofen | TABLET, CHEWABLE;ORAL | 020601-001 | Nov 15, 1996 | DISCN | Yes | No | Start Trial | Start Trial | |||||
J And J Consumer Inc | JUNIOR STRENGTH MOTRIN | ibuprofen | TABLET, CHEWABLE;ORAL | 020601-003 | Nov 15, 1996 | DISCN | Yes | No | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for J And J Consumer Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
J And J Consumer Inc | PEPCID COMPLETE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 020958-001 | Oct 16, 2000 | 5,229,137*PED | Start Trial |
J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET, CHEWABLE;ORAL | 020606-001 | Jun 26, 1996 | 5,489,436 | Start Trial |
J And J Consumer Inc | JUNIOR STRENGTH MOTRIN | ibuprofen | TABLET, CHEWABLE;ORAL | 020601-003 | Nov 15, 1996 | 5,215,755*PED | Start Trial |
J And J Consumer Inc | IMODIUM | loperamide hydrochloride | CAPSULE;ORAL | 017694-001 | Approved Prior to Jan 1, 1982 | 3,714,159 | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for J AND J CONSUMER INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Chewable Tablets | 5 mg and 10 mg | ➤ Subscribe | 2005-03-25 |
➤ Subscribe | Syrup | 5 mg/5 mL | ➤ Subscribe | 2007-03-19 |
➤ Subscribe | Chewable Tablets | 800 mg/ 10 mg/ 165 mg (OTC) | ➤ Subscribe | 2004-11-01 |
International Patents for J And J Consumer Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Portugal | 1404304 | Start Trial |
World Intellectual Property Organization (WIPO) | 03002098 | Start Trial |
Denmark | 1404304 | Start Trial |
Cyprus | 1109238 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for J And J Consumer Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0720599 | 300689 | Netherlands | Start Trial | PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN ATORVASTATINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER ATORVASTATINE CALCIUM TRIHYDRATE; NATIONAL REGISTRATION NO/DATE: RVG114373-114376 20141027; FIRST REGISTRATION: FR 2014091200122 20140912 |
0933372 | 13/2008 | Austria | Start Trial | PRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713 |
2957286 | 300962 | Netherlands | Start Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: EU/1/17/1179 20170721 |
2957286 | 122018000145 | Germany | Start Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.